Fruquintinib disatujuan ku USFDA dina kanker kolorektal métastatik refractory

The Food and Drug Administration approved fruquintinib (Fruzaqla, Takeda Pharmaceuticals, Inc.) on November 8, 2023, for adult patients with metastatic colorectal cancer (mCRC) who have undergone specific prior treatments.The ef..

kasadaran, anggapanana

Bulan Maret nyaéta bulan kasadaran kanker kolorektal

Maret 2023: Dina taun 2020, ampir 2 juta kasus kanker kolorektal bakal didiagnosis sacara global, janten jinis kanker katilu anu paling umum. Éta mangrupikeun panyabab kadua maotna anu aya hubunganana sareng kanker, nyababkeun ampir 1 juta.

fluoropirimidin, HER2-positip, oxaliplatin, Seagen Inc., tucatinib, Tukysa

Persetujuan gancangan dipasihkeun ku FDA ka tucatinib sareng trastuzumab pikeun kanker kolorektal

In February 2023, the Food and Drug Administration (FDA) sped up the approval of tucatinib (Tukysa, Seagen Inc.) and trastuzumab for the treatment of RAS wild-type HER2-positive colorectal cancer that has spread or can not be rem..

ASCO Gudilines

Kanker colorectal tungtunan skrining pang anyarna

Juli 6th 2021: Kanker koloréktal mangrupikeun sabab anu paling sering tina maotna kanker di dunya. Saringan biasa, di sisi anu sanésna, tiasa ngadeteksi kanker koloréktal bari leutik, teu sumebar, sareng panginten langkung gampil diubaran ...

Tumor stromal gastrointestinal nargétkeun ubar Avapritinib

Tumor stromal gastrointestinal nargétkeun ubar Avapritinib (Avapriny, Ayvakit, BLU-285) disatujuan ku USFDA dina 9 Januari, 2020. Ubar ieu nutupan dua indikasi: pikeun pengobatan pasién sawawa kalayan reseksi anu teu tiasa dioperasikeun atanapi m ..

Pangobatan kanker kolorektal PD-1 / PD-L1

Colon cancer immunotherapy, rectal cancer immunotherapy, colorectal cancer immunotherapy, and colorectal cancer PD-1 / PD-L1 treatment. Seventeen years ago, the number of drugs available for advanced colorectal cancer was very li..

Braftovi sareng Erbitux tungtungna ngahontal hasil anu positif pikeun kanker kolorektal

Perlakuan anu ditujukeun pikeun kanker kolorektal, mutasi gén BRAF V600E targét anu ditujukeun pikeun kanker kolorektal Braftovi + Erbitux tungtungna ngahontal hasil anu positip Status perlakuan kanker kolorékal kanker kanker mangrupikeun salah sahiji anu paling ..

Kumaha carana nyegah sareng ngubaran kanker kolorektal anu kambuh?

Kumaha carana nyegah kambuh kanker koloréktal, kumaha ngubaran kambuh kanker koloréktus saatos operasi? Kanker kolorektal mangrupikeun tumor ganas anu umum, kalebet kanker usus besar sareng kanker rektum. Kajadian kanker koloréktal ..

Uji diri kanker peujit, kumaha mariksa kanker peujit?

Tes mandiri kanker usus, kumaha mariksa kanker usus, pamariksaan kanker koloréktal, pamariksaan kanker rektum, naon pamariksaan kanker rektum, naon anu diperiksa pikeun disangka kanker usus. Kanker bowel (biasana disebut kaléng koloréktal ..

Immunotherapy mupus lesions dina kanker kolorektal maju

A meal "eats" colorectal cancer In 2014, 65-year-old Mr. Yang and his wife traveled abroad. During the period, gastrointestinal discomfort and constipation symptoms occurred, but they didn't pay much attention at that time, thinki..